Latest Innovation News

Bio-Gene Technology’s novel acaricide Flavocide demonstrated over 90% mortality against Lyme disease-carrying ticks in lab tests presented by Purdue University, highlighting its potential in public health applications.

Arovella Therapeutics has received a $3.21 million R&D tax incentive refund, bolstering its financial position as it prepares to initiate first-in-human trials for its lead cell therapy, ALA-101.

Impact Minerals Limited has successfully raised $4 million through a heavily oversubscribed placement, positioning the company to advance its High Purity Alumina projects and copper exploration activities.

Loyal Metals reveals a strategic pivot to copper with its Highway Reward mine, tapping into remnant resources and AI-driven exploration to capitalize on soaring commodity prices.

Algorae Pharmaceuticals has secured an exclusive licensing agreement with Sakar Healthcare to introduce five generic oncology medicines in Australia and New Zealand, marking its first commercial foray in the region.

FMR Resources has initiated a significant 4,000-metre diamond drilling program at its Southern Porphyry target within the Llahuin Project JV in Chile, aiming to validate a large porphyry copper system. Assay results from the first drillhole are expected within weeks, marking a pivotal step in the company’s exploration journey.

Sprintex Limited has secured a significant A$16.6 million order to supply integrated control systems for Mest Water’s innovative manure processing units, marking a major step in sustainable agriculture technology in the Netherlands.

Noxopharm Limited has secured an extension on $2.6 million of convertible notes and obtained a $1.25 million unsecured loan to bolster working capital, pending shareholder approval.

Clover Corp has reported a standout FY25 with robust revenue and profit growth, driven by new product launches and strategic investments that strengthen its global supply chain and market reach.

Clover Corporation posted a robust 38% revenue increase to $86 million in FY25, driven by product innovation and operational gains, while declaring a final dividend. The company’s cautious outlook for FY26 reflects ongoing regulatory and production challenges.

Hazer Group has been granted a pivotal patent in Singapore for its proprietary graphite morphology process, reinforcing its foothold in Southeast Asia's clean energy and advanced manufacturing markets.

SiteMinder's 2025 Investor Day presentation highlights its Smart Platform's progress, AI-driven hotel revenue tools, and reiterates a strong FY26 outlook with ambitions for accelerated growth.